12/08/2025
🚨
The BioStabilization Systems (BoSS) program is seeking breakthrough approaches in cell preparation (TA1) and bioprocessing systems (TA2) that can maintain cell potency and expand access to advanced therapies.
🗓️ Solution summaries due:
TA1/TA2: Feb. 19, 2026
IV&V Partner: Apr. 17, 2026
Learn what ARPA-H is looking for and how EverGlade can support your submission strategy: https://hubs.ly/Q03XbZnK0